These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7443872)

  • 1. The use of sulprostone, a prostaglandin E2 derivative, in intrauterine fetal death and therapeutic abortion.
    Lippert TH; Briel RC
    Prostaglandins Med; 1980 Oct; 5(4):259-65. PubMed ID: 7443872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S; Winkler C
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues.
    Di Lieto A; Catalano D; Albano G; Uccello N; Civetta A; Ferrara R; Fimiani R; Pontillo M; Paladini A
    Clin Exp Obstet Gynecol; 1991; 18(4):251-9. PubMed ID: 1790608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulprostone (Nalador) versus gemeprost (Cervagem) for cervical priming in the termination of pregnancy during the first trimester.
    Heinzl S; Hendry M
    Contraception; 1987 Mar; 35(3):271-82. PubMed ID: 3608482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First and midtrimester abortion with intramuscular injections of sulprostone.
    Ballard CA
    Contraception; 1981 Aug; 24(2):145-50. PubMed ID: 7297066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulprostone for preoperative cervical dilatation in primigravidae scheduled for late first trimester termination of pregnancy.
    Jerve F; Fylling P
    Arch Gynecol; 1983; 233(3):199-203. PubMed ID: 6625666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological action and half life in plasma or intramuscular sulprostone for termination of second trimester pregnancy.
    Briel RC; Lippert TH
    Prostaglandins Med; 1981 Jan; 6(1):1-8. PubMed ID: 7220653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of intramuscular sulprostone for second trimester abortion.
    Intaraprasert S; Sugkraroek P
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():58-62. PubMed ID: 3047304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abortion with sulprostone, a prostaglandin E2 derivative.
    Pulkkinen MO; Kajanoja P; Kivikoski A; Saastamoinen J; Selander K; Tuimala R
    Int J Gynaecol Obstet; 1980; 18(1):40-3. PubMed ID: 6106599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervix ripening and labor induction in therapeutic abortion in the middle and late 2d trimester using intracervical and extra-amniotic prostaglandin gel administration].
    Rath W; Ulbrich R; Kuhn W
    Wien Klin Wochenschr; 1985 May; 97(11):486-93. PubMed ID: 3859953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with sulprostone (author's transl)].
    Brabec W; Dapunt O; Bichler A
    Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraamniotic prostaglandin F2 alpha for intrauterine death and fetal abnormality.
    Luengo J; Keirse MJ; Bennebroek Gravenhorst J
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):325-9. PubMed ID: 299460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dinoprostone priming of the cervix prior to termination of midgestation pregnancy with sulprostone.
    Rietberg CC; Lotgering FK; Huikeshoven FJ
    Eur J Obstet Gynecol Reprod Biol; 1995 Jun; 60(2):157-60. PubMed ID: 7641968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with 16-phenoxy-omega-tetranor-PGE2-methylsulfonamide (sulprostone) for termination of second trimester pregnancy.
    Fylling P
    Contraception; 1982 Sep; 26(3):279-83. PubMed ID: 7172674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.